Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03602365 · ClinicalTrials.gov registry record · NA
Gentle Jogger and Oxygen Consumption
A NA study of Physical Inactivity and Oxygen Consumption, sponsored by Sackner Wellness Products.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT03602365: Completed NA study of Physical Inactivity and Oxygen Consumption, sponsored by Sackner Wellness Products.
NCT03602365 is a NA study of Physical Inactivity and Oxygen Consumption that has completed, run by Sackner Wellness Products. The registered enrollment target is 24 participants, below the 225-participant average among 59 other Physical Inactivity trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03602365, a NA study of Physical Inactivity and Oxygen Consumption, has completed, sponsored by Sackner Wellness Products.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a non randomized study to determine the effects of Gentle Jogger(GJ), a passive jogging device on oxygen consumption in 2 postures supine and seated. Oxygen consumption measurements will be performed via indirect calorimetry in duplicate at rest ( supine and seated posture) , and repeated in duplicate during GJ (in supine and seated posture)
Primary Outcome
oxygen consumption measured by indirect calorimetry
Conditions Studied
Interventions
- DEVICE Gentle Jogger (GJ)
Study Locations (1)
Florida
- CIC Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2018-06-01 |
| Est. Completion | 2020-01-23 |
| Phase | NA |
What the finished NCT03602365 record still lists
NCT03602365 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 225-participant average among 59 other Physical Inactivity trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with Physical Inactivity appearing as the primary indexed condition, and to 1 intervention - of which Gentle Jogger (GJ) is the first listed.
NCT03602365 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03602365 about?
NCT03602365 is a clinical study titled "Gentle Jogger and Oxygen Consumption". This is a non randomized study to determine the effects of Gentle Jogger(GJ), a passive jogging device on oxygen consumption in 2 postures supine and seated. Oxygen consumption measurements will be performed via indirect calorimetry in duplicate at rest ( supine and seated posture) , and repeated in...
What is the current status of trial NCT03602365?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2018-06-01. Estimated completion is 2020-01-23.
What conditions does trial NCT03602365 study?
This clinical trial studies the following conditions: Physical Inactivity, Oxygen Consumption.
What interventions are being tested in trial NCT03602365?
The interventions under investigation include: Gentle Jogger (GJ) (DEVICE).
Who is sponsoring clinical trial NCT03602365?
This trial is sponsored by Sackner Wellness Products, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03602365 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Physical Inactivity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03602365's enrollment target sits among peer trials
24 57th of 59 higher than 2 of 59 other Physical Inactivity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Physical Inactivity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Pilot Factorial Trial of an Integrated Lifestyle Intervention
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Promoting Physical Activity in Older Hispanic/Latino(a) Adults
RECRUITING · NA
-
ENRICH Nurse-Family Partnership Study
RECRUITING · NA
-
Impact of Dietary Phosphate Excess on Exercise Capacity and Visceral Adiposity
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI